Giorgio Ramadori

Giorgio Ramadori

Auto-generated profile, based on publicly available information

Giorgio Ramadori

Department of Cell Physiology and Metabolism, University of Geneva , Geneva 1211

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in Cell Metabolism
Verified
Journal Article
Closed access
NPNathan L. Price
Nathan L. Price
AGAna P. Gomes
Ana P. Gomes
ALAlvin J.Y. Ling
Alvin J.Y. Ling
Filipe V DuarteFilipe V Duarte
Filipe V Duarte
Alejandro MartinAlejandro Martin
Alejandro Martin
DSDavid A. Sinclair
David A. Sinclair

1 October 2008 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
GRGiorgio Ramadori
Giorgio Ramadori
CLCharlotte E. Lee
Charlotte E. Lee
ABAngie L. Bookout
Angie L. Bookout
SLSyann Lee
Syann Lee
KWKevin W. Williams
Kevin W. Williams
RCRoberto Coppari
Roberto Coppari
SIRT1 is a nicotinamide adenosine dinucleotide-dependent deacetylase that orchestrates key metabolic adaptations to nutrient deprivation in peripheral tissues. SIRT1 is induced also in the brain by reduced energy intake. However, very little is known about SIRT1 distribution and the biochemical phenotypes of SIRT1-expressing cells in the neuraxis. Unknown are also the brain sites in which SIRT1 is regulated by energy availability and whether these regulations are altered in a genetic model of obesity. To address these issues, we performedin situhybridization histochemistry analyses and found thatSirt1mRNA is highly expressed in metabolically relevant sites. These include, but are not limited to, the hypothalamic arcuate, ventromedial, dorsomedial, and paraventricular nuclei and the area postrema and the nucleus of the solitary tract in the hindbrain. Of note, our single-cell reverse transcription-PCR analyses revealed thatSirt1mRNA is expressed in pro-opiomelanocortin neurons that are critical for normal body weight and glucose homeostasis. We also found that SIRT1 protein levels are restrictedly increased in the hypothalamus in the fasted brain. Of note, we found that this hypothalamic-specific, fasting-induced SIRT1 regulation is altered in leptin-deficient, obese mice. Collectively, our findings establish the distribution ofSirt1mRNA throughout the neuraxis and suggest a previously unrecognized role of brain SIRT1 in regulating energy homeostasis.

1 July 2010 in Cell Metabolism
Verified
Journal Article
Closed access
GRGiorgio Ramadori
Giorgio Ramadori
TFTeppei Fujikawa
Teppei Fujikawa
MFMakoto Fukuda
Makoto Fukuda
JAJason Anderson
Jason Anderson
DMDonald A. Morgan
Donald A. Morgan
RCRoberto Coppari
Roberto Coppari

20 September 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TFTeppei Fujikawa
Teppei Fujikawa
JCJen-Chieh Chuang
Jen-Chieh Chuang
ISIchiro Sakata
Ichiro Sakata
GRGiorgio Ramadori
Giorgio Ramadori
RCRoberto Coppari
Roberto Coppari
Leptin monotherapy reverses the deadly consequences and improves several of the metabolic imbalances caused by insulin-deficient type 1 diabetes (T1D) in rodents. However, the mechanism(s) underlying these effects is totally unknown. Here, we report that intracerebroventricular (icv) infusion of leptin reverses lethality and greatly improves hyperglycemia, hyperglucagonemia, hyperketonemia, and polyuria caused by insulin deficiency in mice. Notably, icv leptin administration leads to increased body weight while suppressing food intake, thus correcting the catabolic consequences of T1D. Also, icv leptin delivery improves expression of the metabolically relevant hypothalamic neuropeptides proopiomelanocortin, neuropeptide Y, and agouti-related peptide in T1D mice. Furthermore, this treatment normalizes phosphoenolpyruvate carboxykinase 1 contents without affecting glycogen levels in the liver. Pancreatic β-cell regeneration does not underlie these beneficial effects of leptin, because circulating insulin levels were undetectable at basal levels and following a glucose overload. Also, pancreatic preproinsulin mRNA was completely absent in these icv leptin-treated T1D mice. Furthermore, the antidiabetic effects of icv leptin administration rapidly vanished (i.e., within 48 h) after leptin treatment was interrupted. Collectively, these results unveil a key role for the brain in mediating the antidiabetic actions of leptin in the context of T1D.

1 September 2011 in Cell Metabolism
Verified
Journal Article
Closed access
GRGiorgio Ramadori
Giorgio Ramadori
TFTeppei Fujikawa
Teppei Fujikawa
JAJason Anderson
Jason Anderson
EBEric D. Berglund
Eric D. Berglund
RFRenata Frazao
Renata Frazao
RCRoberto Coppari
Roberto Coppari

1 September 2013 in Cell Metabolism
Verified
Journal Article
Closed access
TFTeppei Fujikawa
Teppei Fujikawa
EBEric D. Berglund
Eric D. Berglund
VPVishal R. Patel
Vishal R. Patel
GRGiorgio Ramadori
Giorgio Ramadori
CVClaudia R. Vianna
Claudia R. Vianna
RCRoberto Coppari
Roberto Coppari